We review public and private payer policies, including Medicare Part D and Medicaid rules, and highlight recent policy proposals and industry trends affecting GLP-1 access
A greater reduction in body weight, cholesterol, triglycerides, fasting glucose, insulin, and HOMA-IR was achieved with the higher dose of tirzepatide, demonstrating a clear dose-dependent improvement
These numbers add up quickly, and choosing the cheapest option means nothing if the medication does not work
Learning to read a clinics menu by examining whats in an IV drip reveals which nutrients are present, at what doses, rather than relying on marketing names alone
The effect varies by medication, dose, and whether the drug is used for diabetes or obesity, but the overall pattern is clear